drugset / Trial / NCT01546688

A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

NCT01546688

Phase 4 Terminated 41 enrolled Eisai Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A two arm, randomized, double-blind study comparing zonisamide with placebo. The zonisamide arm will consist of 100 subjects and the placebo arm of 50 subjects. Study medication will be administered as an add-on treatment to the subject's current 1 or 2 anti-epileptic (AEDs).

Timeline

Start
2008-11
Primary completion
2010-11
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zonisamide Other / unclassified 100 mg
Comparator Zonisamide Other / unclassified 500 mg

Indications